Abstract

The drug services firm ElevateBio and the University of Pittsburgh plan to establish a process development and manufacturing campus for cell and gene therapy in Hazelwood Green, a waterfront development in Pittsburgh. The project is intended to replicate Elevate’s BaseCamp, a 13,000 m 2 facility that opened last year in Waltham, Massachusetts. Supported by a $100 million grant from the Richard King Mellon Foundation, the new center is expected to create 170 jobs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.